Skip to main content
Loading

Scale-up and manufacturing challenges for complexes Oligo such as sgRNA, peptide-oligo conjugate and antibodies oligo conjugate

26 Sep 2025
Oligonucleotide CMC & Process Development
  • Oligo chemical synthesis
  • Downstream processing/purification 
  • Analytic development and specifications
  • How to reduce the cost of CRISPR therapies
  • Which CDMO should you choose for your modality
Industry Expert
Marc Jacob, Head of Strategic Development - YMC America

YMC America